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Abstract: 
Background: 
Few studies have comprehensively investigated the validity of self-reported hypertension (HTN) 
and assessed predictors of HTN status in the stroke belt. This study evaluates validity self-
reporting as a tool to screen large study populations and determine predictors of congruency 
between self-reported HTN and clinical measures. 
Methods: 
Community Initiative to Eliminate Stroke project (n = 16,598) was conducted in two counties of 
North Carolina in 2004 to 2007, which included collection of self-reported data and clinical data 
of stroke-related risk factors. Congruency between self-reported HTN status and clinical 
measures was based on epidemiological parameters of sensitivity, specificity, and predictive 
values. McNemar’s test and Kappa agreement levels assessed differences in congruency, while 
odds ratios and logistic regression determined significant predictors of congruency. 
Results: 
Sensitivity of self-reported HTN was low (33.3%), but specificity was high (89.5%). Prevalence 
of self-reported HTN was 16.15%. Kappa agreement between self-report and clinical measures 
for blood pressure was fair (k = 0.25). Females, whites, and young adults were most likely to be 
positively congruent, whereas individuals in high risk categories for total blood cholesterol, low 
density lipoproteins, triglycerides, and diabetes were least likely to accurately capture their HTN 
status. 
Conclusion: 
Self-report HTN information should be used with caution as an epidemiological investigation 
tool. 
Keywords: Hypertension | validation | self-reports | sensitivity | systolic blood pressure | 
diastolic blood pressure 
Article:  
Introduction 
Hypertension (HTN) is a silent killer affecting one in three U.S. adults.1 In 2010, it was 
estimated that HTN cost the U.S. $76.6 billion in missed days from work and medical care, 
including medications.2 HTN is a major risk factor for cardiovascular disease (CVD) and stroke, 
which are among the three leading causes of death in the U.S.3 According to the Framingham 
Heart Study, the lifetime risk for developing HTN after the age of 55 years is 90% for both 
nonhypertensive men and women.4 Since the inception of the National High Blood Pressure 
Education Program in 1972, there have been continued efforts to raise awareness, treat, and 
control HTN, but unfortunately, uncontrolled blood pressure (BP) levels continue to remain 
high.2, 5, 6 and 7Therefore, it is imperative to enhance epidemiological surveillance and population-
based public health strategies aimed at secondary prevention of HTN and primary prevention of 
CVDs and stroke. 
Typically, epidemiological studies that are focused on HTN, its risk factors, and its outcomes 
require large sampling populations and assessment of clinical measures. These studies can get 
very time-consuming and expensive.5, 8, 9, 10 and 11 Therefore, emphasis is placed on conducting 
small-scale, cross-sectional or cohort studies, and rely on self-reported information about one's 
HTN status.5, 8, 9, 10, 11, 12 and 13 These small-scale studies can be conducted at local or state levels 
and are practical, inexpensive, and can be comprehensively assessed. Results from these studies 
would enable health researchers and practitioners to design community-based interventions 
targeting populations in most need. The Community Initiative to Eliminate Stroke (CITIES) 
project of North Carolina (NC) was a 3-year small-scale project implemented in two NC 
counties, Guilford and Forsyth, and targeted persons of color, low-income, and rural residency as 
well as persons for whom English was a second language. The main components of the project 
were: (a) to screen individuals and assess self-reported and clinical risk factors of stroke; (b) 
make recommendations and referrals as appropriate for identified risk factors; and (c) provide 
health education and health promotion activities to reduce the prevalence of stroke risk factors. 
The National Health and Nutrition Examination Survey (NHANES) program has collected self-
reported data in combination with physical data since 1960.14 Studies examining the trends in 
NHANES data found between 1999 and 2010 the prevalence of HTN remained high while 
awareness, management, and control of HTN remained poor. Their findings were consistent with 
those from other studies as well.15, 16 and 17 The Centers for Disease Control has recognized the 
bias and possible errors in using self-reported data, but determined that, for large population-
based studies, self-reported data may be most accurate.14 In assessing self-reported risk factor 
data, it is important to pay particular attention to the validity of the information collected and 
how well this information reflects the clinical measures of BP levels.5, 9, 10, 11, 18 and 19 Validity 
studies involve epidemiologic assessment and reporting of sensitivity, specificity, and predictive 
values. Few studies have evaluated the validity of self-reported information in the U.S., 
particularly at regional and state levels.9, 11 and 20 Furthermore, very little is known about the 
predictors of congruency between self-reported information and one's actual HTN status. 
Albeit these studies have found mild to moderate sensitivity and high specificity, 
recommendations to utilize self-report as a valid tool to screen large numbers of individuals have 
been mixed. Even guidelines and definitions for both self-report and clinical measures of BP 
have evolved over the last three decades. Therefore, the interpretation of results in some of these 
studies becomes difficult in light of the current Seventh Report of the Joint National Committee 
on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) guidelines 
and definition of HTN. 
The purpose of this paper is two-fold: (a) to assess the validity of self-reported HTN status 
compared with clinical measures of BP levels in a cross-sectional pool of participants from the 
CITIES project using the most current JNC guidelines; and, (b) to determine predictors of the 
level of congruency between one's self-reported information and actual BP measures at the state 
level. This assessment will not only allow investigators to evaluate self-reported data as an 
expedient and reliable tool to screen larger numbers, but also enable health professionals to 
design and implement targeted educational messages aimed at raising awareness of HTN and its 
risk factors. 
Methods 
Settings and Procedures 
Registered nurses (RNs) used mobile units to screen individuals at sites such as churches, 
factories, health fairs, etc. within the two respective counties. A total of 19,621 individuals were 
screened for stroke risk factors in the CITIES project. Participation was voluntary, and each 
participant was included in this study if they were 18 years or older and signed the consent form. 
The RNs used a standard questionnaire that was divided into three distinct categories, including 
demographic information, self-reported stroke risk factors, and clinical and biomedical measures 
of stroke risk factors.21 The participants were asked to self-report their HTN status by answering 
the following question: “Do you suffer from high blood pressure and/or has a 
physician/doctor/nurse diagnosed you as a hypertensive?” Inclusion criteria was based on a ‘yes’ 
response to the question. 
The RNs measured the blood pressure of each participant using an electronic machine, 
DINAMAP (General Electric Healthcare, Bukinghamshire, UK), which was wet-tested and 
calibrated every week. A minimum of two measures were taken in the seated position with the 
arms outstretched, and the lowest BP reading was recorded. If the first reading was high, then BP 
was measured again after 2 minutes in the same arm. If the readings on the machine were found 
to be high on both occasions, then the registered nurses would manually measure the blood 
pressure twice in the other arm using a calibrated sphygmomanometer, and then record the 
lowest readings. 
Other self-reported information included overweight status, smoking, exercise status, and use of 
BP-lowering and lipid-lowering medications. All self-reported information was collected prior to 
measuring BP and collection of blood samples. Clinical and biomedical measures included blood 
low density lipoproteins, high density lipoproteins (HDL), total cholesterol, triglycerides, and 
glucose levels. Blood measures were obtained using finger prick blood screening procedures. 
Body mass index (BMI) was calculated based on height and weight measures. The RNs also 
collected demographic information such as age, gender, education, etc. from all participants. The 
project was approved by the respective Institutional Review Boards for all institutions. 
Statistical Analyses 
JNC 7 defines HTN as having a systolic BP level of 140 mm Hg or more and/or diastolic BP 
levels of 90 mm Hg or more. Our gold standard, that is, possible diagnosis of HTN in our 
sample, was computed based on systolic and diastolic blood pressure levels and classification 
parameters of HTN proposed by JNC 7.4 Thus, possible diagnosis of HTN was defined as 
systolic BP levels of 140 mm Hg and/or diastolic BP of 90 mm Hg or more. MS Access 
(Microsoft Corp, Redmond, Wash) was used to input data, which was analyzed using SPSS 18 
(IBM, Armonk, NY).22 and 23 
The final sample excluded individuals who were taking BP-lowering medications in order to 
avoid confounding and overestimation of sensitivity of the screening test. The participants’ 
demographic characteristics, self-reported information, and clinical measures were described 
using frequencies and percentages. Bivariate associations were calculated using cross-tabulations 
to compare self-reported information (‘yes’ and ‘no’) from the questionnaire with possible 
diagnosis of HTN (‘yes’ and ‘no’) based on BP measures. The validity of the self-reported 
information was evaluated on the basis on sensitivity, specificity, and positive and negative 
predictive values. In addition, we also conducted separate analysis to test the validity of self-
reported information by including, in our final sample, a subsample of previously excluded 
individuals (those taking antihypertensive medications). McNemar’s test was used to ascertain 
differences between positively congruent individuals and those who were negatively congruent. 
Kappa (κ) scores were used to assess agreement between self-reported status and possible 
diagnosis of HTN. A κ score of less than 0.20 was considered poor agreement, 0.20 to 0.40 fair 
agreement, 0.41 to 0.60 moderate agreement, 0.61 to 0.80 substantial agreement, and more than 
0.81 as almost perfect agreement.24 
The dependent outcome variable between self-reported information and clinical data was 
computed using the cross-tabulations for self-reported and possible diagnosis of HTN. The 
outcome variable – congruence (positive or negative) – was defined as the state of agreement 
between self-reported (yes or no) and possible diagnosis of HTN (yes or no). Positive 
congruence was taken as a measure of being aware of one’s HTN status given a possible 
diagnosis of HTN, whereas negative congruence was taken as a measure of being unaware of 
one’s HTN status given a possible diagnosis of HTN. Odds ratios and confidence intervals (CI) 
at 95% were calculated using standard procedures to assess determinants of positive congruency. 
The outcome variable that is the state of agreement between self-reported and possible diagnosis 
of HTN was modeled as a function of independent variables including demographic 
characteristics, self-reported information, and clinical measures. Binary logistic regression and 
forward likelihood ratio method were used to evaluate statistically significant predictors of HTN 
congruency. The statistical significance for all analyses was based on the conventional alpha 
level of significance of 0.05. 
Results 
Table 1 presents the demographic characteristics of the participants. A majority of the 
participants in the CITIES project were females. Approximately 50% of the participants were 
Caucasians. More than half (62.2%) of the participants were aged 41 years or older, with a mean 
age of 45.26 (standard deviation, 13.9). Approximately 60% of the participants reported an 
annual income of less than $35,000, while more than half of the participants had more than high 
school education. 
Table 1. Demographic characteristics of respondents∗ in CITIES project, NC (2004–2007) 
Personal Characteristics Totals 
 
N (16,598) % 
Gender 
 Male 5747 36.3 
 Female 10,087 63.7 
Race 
 Caucasian 7329 47.1 
 African American 6758 40.7 
 Hispanic 514 3.3 
 Asian/Pacific Islander 456 2.9 
 Other 513 3.1 
Age 
 18 to 40 years old 5965 38.0 
 41 to 55 years old 6285 40.0 
 ≥56 years old 3454 22.0 
Income 
 <$35,000 9735 64.7 
 ≥$35,000 5308 35.3 
Education 
 Less than high school 1122 7.2 
 High school or General Educational Development 4598 29.5 
 More than high school 9859 63.3 
Ethnicity 
 Hispanic/Latino 514 3.3 
 Non-Hispanic/Latino 15,056 96.7 
∗Totals do not sum to the sample size due to missing data. 
Self-reported risk information is presented in Table 2. Almost 85% of the participants self-
reported ‘no,’ when they were asked, “Do you suffer from high blood pressure and/or has a 
physician/doctor/nurse diagnosed you as a hypertensive?” The results of the clinical measures of 
the participants are reported in Table 3. Less than one-quarter, that is 20.5% and 14.2%, of the 
participants had systolic or diastolic HTN in stages I or II, respectively. Among those who self-
reported as having HTN, slightly more than half of the participants were confirmed to have 
clinical HTN stages I or II for a positive predictive value of 51.2%. More than three-quarters 
(80.3%) of the participants who self-reported as nonhypertensive were confirmed not to have a 
possible diagnosis of clinical HTN stages I or II. Overall, the sensitivity of self-report for 
correctly identifying those who have HTN was 33.31%, while the specificity, that is, correctly 
identifying those who did not have HTN, was 89.5%. The prevalence of HTN in this sample was 
16.15% based on self-reporting and 24.81% based on clinical measures of BP. A separate 
analysis using our original sample (n = 16,598) and adding previously excluded individuals, that 
is those taking antihypertensive medications (n = 2663), found the sensitivity and specificity self-
reporting was 49.56% and 80.29%, respectively. The overall prevalence rate of HTN with the 
sub-sample (n = 2663) included to our final sample was 28.1%. McNemar’s test showed that 
there was a statistically significant difference between those who were positively congruent and 
those who were not (P < .05). The overall κ score for agreement between self-reported and 
clinical measures of BP was 0.25. The multivariate logistic regression found that gender 
(P < .01), race (P < .01), age (P < .01), family history of CVD (P < .01), self-reported diabetes 
status (P < .05), total blood cholesterol (P < .15), HDL levels (P < .01), blood triglyceride levels 
(P < .01), and BMI (P < .01) were statistically significant predictors of congruency (see Table 4). 
These results were similar to the bivariate associations discussed above. Cross-tabulations and 
unadjusted odds ratios (ORs) were conducted to further explore level of congruency between 
select groups of individuals that were found to be significant predictors. Approximately four-
fifths of the participants (88%) that were white females aged 18 to 40 years old were positively 
congruent, that is, more aware of their HTN status (n = 3768). 
Table 2. Self-reported characteristics of respondents∗ in CITIES project, NC (2004–2007) 
Self-reported Characteristics Totals 
 
N (16,598) % 
Personal history of CVD 
 Yes 701 4.2 
 No 15,897 95.8 
History of atrial fibrillation 
 Yes 7329 47.1 
 No 6758 40.7 
Family history of CVD 
 Yes 3868 23.3 
 No 12,730 76.7 
Smoking status 
 Yes 2880 17.4 
 No 13,718 82.6 
Overweight status 
 Yes 8248 49.7 
 No 8350 50.3 
Lack of exercise status 
 Yes 7891 47.5 
 No 8707 52.5 
Hypertension status 
 Yes 2555 15.4 
 No 14,043 84.6 
High blood cholesterol status 
 Yes 2771 16.7 
 No 13,827 83.3 
Diabetes status 
 Yes 868 5.2 
 No 15,730 94.8 
Stress status 
 Yes 3726 22.4 
 No 12,872 77.6 
CVD, cardiovascular disease. 
∗Totals do not sum to the sample size due to missing data. 
 
Table 3. Clinical characteristics of respondents∗ in CITIES project, NC (2004–2007) 
Clinical Characteristics Totals 
 
N (16,598) % Mean 
Low density lipoprotein   108.54 mg/dL 
 Very high risk (≥190 mg/dL) 297 2.3  
 High risk (160–189 mg/dL) 892 7.0  
 Borderline high risk (130–159 mg/dL) 2646 20.7  
 Near optimum/above optimum (100–129 mg/dL) 5076 39.7  
 Optimum (≤99 mg/dL) 3874 30.3  
High density lipoprotein   50.32 mg/dL 
 High risk (<40 mg/dL) 4072 26.1  
 Normal (40–59 mg/dL) 7678 49.1  
 Preventive (≥60 mg/dL) 3876 24.8  
Total cholesterol   189.1 mg/dL 
 High risk (≥240 mg/dL) 1537 9.8  
 Moderate risk (200–239 mg/dL) 4214 26.8  
 Normal (≤199 mg/dL) 9959 63.4  
Triglyceride   155.55 mg/dL 
 High risk (≥200 mg/dL) 3605 23.0  
 Borderline high risk (150–199 mg/dL) 2696 17.2  
 Optimum (≤149 mg/dL) 9378 59.8  
Blood glucose   100.91 mg/dL 
 High risk (≥200 mg/dL) 261 1.7  
 Moderate risk (150–199 mg/dL) 472 3.0  
 Normal (50–149 mg/dL) 14,995 95.3  
Body mass index   28.60 
 Obese (≥30) 5318 34.0  
 Overweight (25–29.9999) 5496 35.1  
 Normal (18.5–24.9999) 4623 29.5  
 Underweight (≤18.5) 209 1.4  
Systolic blood pressure   127 mm Hg 
 Hypertension stage II (≥160 mm Hg) 666 4.2  
 Hypertension stage I (140–159 mm Hg) 2560 16.3  
 Prehypertension (120–139 mm Hg) 7079 45.0  
 Normal (≤119 mm Hg) 5428 34.5  
Diastolic blood pressure   78.98 mm Hg 
 Hypertension stage II (≥100 mm Hg) 431 2.7  
 Hypertension stage I (90–99 mm Hg) 1816 11.5  
 Prehypertension (80–89 mm Hg) 5128 32.6  
 Normal (≤79 mm Hg) 8358 53.2  
Combined blood pressure (systolic and diastolic)   NA 
 Hypertension stages I and/or II 1519 9.7  
 Normal and/or prehypertension 14,122 90.3  
∗Totals do not sum to the sample size due to missing data. 
Table 4. Logistic regression: predictors of negative congruency by demographic, self-reported, 
and clinical characteristics in CITIES project, NC (2004–2007) 
Participant Characteristics β Odds Ratio (95% CI) P 
Gender 
 Female (reference) – – – 
 Male 0.329 1.389 (1.261, 1.530)* .00 
Race 
 Caucasian (reference) – – – 
 African Americans 0.163 1.178 (1.069, 1.296)* .00 
 Hispanics/Latinos 0.313 1.367 (1.028, 1.817)* .03 
 Asians/Pacific Islander 0.152 1.165 (0.883, 1.537) .28 
 Others 0.145 1.156 (0.887, 1.507) .28 
Family history of CVD 
 No (Reference) – – – 
 Yes 0.175 1.191 (1.078, 1.316)* .00 
Diabetes status 
 No (Reference) – – – 
 Yes 0.214 1.238 (1.021, 1.281)* .03 
Triglycerides    
 Normal (reference) – – – 
 Moderate risk 0.129 1.137 (1.010, 1.281)* .03 
 High risk 0.210 1.234 (1.095, 1.391)* .00 
High density lipoprotein levels    
 Preventive (reference) – – – 
 Normal −0.156 0.856 (0.761, 0.962)* .00 
 High risk −0.051 0.950 (0.824, 1.097) .48 
Age 
 18 to 40 years old (reference) – – – 
 41 to 55 years old 0.632 1.881 (1.688, 2.097)* .00 
 Older than 55 years old 1.088 2.969 (2.628, 3.354)* .00 
Total blood cholesterol levels 
 Normal (reference) – – – 
 Moderate risk 0.140 1.151 (1.041, 1.272)* .00 
 High risk 0.235 1.264 (1.096, 1.459)* .00 
Body mass index 
 Normal (reference) – – – 
 Underweight −0.150 0.861 (0.538, 1.371) .53 
 Overweight 0.295 1.343 (0.842, 2.143) .22 
 Obese 0.610 1.841 (1.152, 2.941)* .11 
CVD, cardiovascular disease. 
χ2 = 4.654*. 
*Significant at P < .05. 
 
Discussion 
Our results indicate that the overall prevalence of hypertension was approximately 23%, less 
than the national prevalence of 29.5% during 2009 to 2010.25 Two reasons why our sample 
exhibited lower prevalence compared with the national trends are: 1) our sample excluded 
individuals who were taking any BP-lowering medications to avoid confounding and inflating 
the number of true negatives or false positives. Upon conducting a separate analysis by including 
these individuals in the original sample, we found that the overall prevalence of HTN was 
28.1%, which is comparable to the national trends. 2) Our sample also included younger 
individuals who were 18 to 20 years old as opposed to national results that typically include 
individuals 20 years and older. Our results indicate that the level of congruency between self-
reported and clinical measures of HTN is low. The sensitivity of self-reported HTN status was 
only 33%. In comparison, other studies that have employed a heterogeneity of research 
methodologies to investigate validity reported a moderate to high sensitivity of approximately 
50% to 90%.9, 10, 11, 13, 18, 20, 26, 27, 28, 29, 30, 31 and 32 Only one study, the Utrecht Health Project, 
reported results similar to ours with a sensitivity of 34.5%.19Conversely, the specificity of self-
reported HTN status of 89.5% in our sample was high and was similar to specificity reported in 
other studies.9, 10, 11, 13, 18, 19, 20, 26, 27, 28, 30, 31 and 32 The results of high specificity are particularly 
encouraging, since it has been postulated that, in the long-term, new incident cases of HTN will 
be eventually diagnosed upon long-term follow-up.5 
We used McNemar’s test and kappa score classification to measure the strength of agreement 
between self-reported and clinical measures of HTN.24 The overall κ scores indicated only fair 
agreement between the two in comparison to other studies that have shown a moderate to 
substantial agreement.5, 9, 10, 12, 28, 32 and 33Two reasons why validity of self-reported HTN was low 
in our sample could be because HTN has a less clear-cut diagnostic criterion in comparison to 
other diseases, like diabetes, fractures, and breast cancer, and HTN is a silent killer that does not 
present clinical signs and symptoms on a daily basis.8 and 19 As a result, the clinical measures, 
diagnosis, and short- and long-term implications of having HTN may not be easily perceived and 
understood by the patient. Therefore, it becomes increasingly important for physicians to 
accurately assess, diagnose, and treat HTN and for health professionals to raise awareness of the 
condition among both physicians and patients. 
We also found that certain subgroups in our sample were more congruent, that is, able to report 
their HTN status more accurately compared with others. Females, whites, and younger adults 
were more accurately aware of their HTN status. Similarly, persons who self-reported as normal 
weight, without a personal or family history of CVD, and without diabetes were also generally 
more aware of their HTN status compared with those who reported a history of CVD, diabetes, 
and/or felt they were overweight or obese. Similar findings have been reported by Muhajarine 
et al.34 Interestingly, our analysis found that individuals who fell into high-risk categories for 
blood cholesterol, low density lipoproteins, HDL, triglycerides, glucose levels, and/or BMI were 
least likely to be congruent compared with individuals who were found to be within normal 
limits for any of those levels. Based on these findings, it seems that individuals who feel that 
they are unhealthy based on their self-reported overweight and exercise status or those who have 
high risk factors for developing HTN or any other CVD appear to be least aware of their HTN 
status. One hypothesis for this occurrence could be that these individuals are less likely to see a 
physician for annual check-ups, thereby falling into a vicious cycle of not knowing what their 
actual health assessment is, leading to a lack of awareness of clinical correlates of HTN and 
CVD and its associated prevention strategies. These individuals then continue to engage in 
unhealthy behaviors and are thus less likely to change or modify lifestyle behaviors for the 
betterment of their health. 
Giles et al have found that individuals who had a preventive health care check-up in the last year 
were more likely to be aware of their HTN status.13 This finding supports the notion that public 
health campaigns designed to raise awareness of HTN and its correlates should also focus on 
encouraging individuals to access preventive care services, that is, getting annual physical check-
ups. The diabetes education and screening program conducted at Smith Island showed that 
participants became more aware of their health risks associated with diabetes, HTN, and high 
cholesterol as a result of the screenings and counseling offered during the screening 
services.35 Moreover, the follow-up rates for annual clinic visits increased due to continued 
efforts to raise awareness and educate residents about these conditions. Although this program 
was focused on diabetes, interventions targeting HTN could be modeled after the Smith Island 
program to raise awareness of the risk factors of HTN and highlight the importance of periodic 
health check-ups. 
The strengths of this study include a large cross-sectional sample size and the availability of 
clinical measures of BP and other associated correlates. Almost half of our sample included 
African Americans, who are at the highest risk of developing hypertension at an early age, reach 
advanced levels of hypertension, are prone to experience further complications, and are less 
likely to attain control of their hypertension.36Furthermore, this study was conducted in one of 
the stroke belt states, NC, which has higher than average stroke mortality rates. Therefore, the 
results from this study could be used to inform future education strategies and interventions, 
especially in other southeastern states with high stroke mortality rates targeting minority 
populations. All individuals who self-reported as taking BP-lowering medications were excluded 
from this study. Since these individuals were automatically considered as self-reported 
hypertensive, their inclusion would have led to an over-estimation of sensitivity of the screening 
test. 
One limitation of this study was that participation in this study was voluntary as opposed to 
recruitment of a more generally representative segment of the population. As a result, this study 
may have missed capturing information from nonparticipants with a different set of knowledge 
about HTN and its correlates. Another limitation of the study was the use of only two readings of 
clinical BP in order to determine possible diagnosis of HTN. The clinical measures of BP varies 
during the day and from day-to-day; therefore, more stringent criteria have been suggested to 
diagnose HTN in order to avoid over-estimation of clinical HTN.6, 9, 37,38 and 39 Another possible 
limitation is ‘white-coat HTN,’ which reflects the stressful influence of nurses and the presence 
of clinical staff on one's BP.9 and 40 
In summary, self-reported information for HTN should be used only with great care as a 
screening tool in large, population-based studies. This study found that individuals who had a 
possible diagnosis of HTN based on their clinical measures were likely to report as not having 
HTN. Thus self-reporting could lead to an under-estimation of the prevalence of HTN in our 
population. Several participant characteristics were identified as potential predictors of decreased 
awareness of one's HTN status, including males, African-Americans, those age 55 years and 
older, and those who were in a high-risk category for several HTN and CVD correlates. Future 
interventions should employ strategies that increase availability and encourage participation of 
individuals in preventative care services, including getting an annual physical. Although the 
diagnosis of HTN is a more involved process, future research could focus on evaluating the 
accuracy of screening data as an indicator of actual diagnosis of HTN. 
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